Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MH-004 by Minghui Pharmaceutical (Shanghai) for Vitiligo: Likelihood of Approval
MH-004 is under clinical development by Minghui Pharmaceutical (Shanghai) and currently in Phase II for Vitiligo. According to GlobalData, Phase...